Nocardia and Aspergillus Coinfection in a Patient with Ulcerative Colitis during Golimumab Therapy

J Crohns Colitis. 2016 Sep;10(9):1127-8. doi: 10.1093/ecco-jcc/jjw064. Epub 2016 Mar 3.

Authors

Maite Alonso-Sierra¹, Marta Calvo², Yago González-Lama²

Affiliations

¹ Gastroenterology Department, Clínica Universidad de Navarra, Pamplona, Spain [email protected].
² Gastroenterology and Hepatology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.

PMID: 26944414
DOI: 10.1093/ecco-jcc/jjw064

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal / therapeutic use
Aspergillosis / complications
Aspergillosis / diagnosis*
Aspergillosis / immunology
Aspergillus fumigatus / isolation & purification
Coinfection / complications
Coinfection / diagnosis*
Coinfection / immunology
Colitis, Ulcerative / complications
Colitis, Ulcerative / drug therapy*
Colitis, Ulcerative / immunology
Humans
Immunocompromised Host
Immunosuppressive Agents / adverse effects*
Immunosuppressive Agents / therapeutic use
Male
Middle Aged
Nocardia Infections / complications
Nocardia Infections / diagnosis*
Nocardia Infections / immunology
Opportunistic Infections / complications
Opportunistic Infections / diagnosis*
Opportunistic Infections / immunology

Substances

Antibodies, Monoclonal
Immunosuppressive Agents
golimumab